Abstract

Sudden Unexpected Death in Epilepsy is a leading cause of epilepsy-related mortality, and the analysis of mouse Sudden Unexpected Death in Epilepsy models is steadily revealing a spectrum of inherited risk phenotypes based on distinct genetic mechanisms. Serotonin (5-HT) signalling enhances post-ictal cardiorespiratory drive and, when elevated in the brain, reduces death following evoked audiogenic brainstem seizures in inbred mouse models. However, no gene in this pathway has yet been linked to a spontaneous epilepsy phenotype, the defining criterion of Sudden Unexpected Death in Epilepsy. Most monogenic models of Sudden Unexpected Death in Epilepsy invoke a failure of inhibitory synaptic drive as a critical pathogenic step. Accordingly, the G protein-coupled, membrane serotonin receptor 5-HT2C inhibits forebrain and brainstem networks by exciting GABAergic interneurons, and deletion of this gene lowers the threshold for lethal evoked audiogenic seizures. Here, we characterize epileptogenesis throughout the lifespan of mice lacking X-linked, 5-HT2C receptors (loxTB Htr2c). We find that loss of Htr2c generates a complex, adult-onset spontaneous epileptic phenotype with a novel progressive hyperexcitability pattern of absences, non-convulsive, and convulsive behavioural seizures culminating in late onset sudden mortality predominantly in male mice. RNAscope localized Htr2c mRNA in subsets of Gad2+ GABAergic neurons in forebrain and brainstem regions. To evaluate the contribution of 5-HT2C receptor-mediated inhibitory drive, we selectively spared their deletion in GAD2+ GABAergic neurons of pan-deleted loxTB Htr2c mice, yet unexpectedly found no amelioration of survival or epileptic phenotype, indicating that expression of 5-HT2C receptors in GAD2+ inhibitory neurons was not sufficient to prevent hyperexcitability and lethal seizures. Analysis of human Sudden Unexpected Death in Epilepsy and epilepsy genetic databases identified an enrichment of HTR2C non-synonymous variants in Sudden Unexpected Death in Epilepsy cases. Interestingly, while early lethality is not reflected in the mouse model, we also identified variants mainly among male Sudden Infant Death Syndrome patients. Our findings validate HTR2C as a novel, sex-linked candidate gene modifying Sudden Unexpected Death in Epilepsy risk, and demonstrate that the complex epilepsy phenotype does not arise solely from 5-HT2C-mediated synaptic disinhibition. These results strengthen the evidence for the serotonin hypothesis of Sudden Unexpected Death in Epilepsy risk in humans, and advance current efforts to develop gene-guided interventions to mitigate premature mortality in epilepsy.

Highlights

  • Sudden Unexpected Death in Epilepsy (SUDEP) is a leading cause of mortality in individuals with epilepsy, accounting for nearly 3000 deaths per year in the U.S.1–3 In patients with chronic refractory epilepsy, SUDEP is diagnosed as the cause of death in up to 50% of cases.[4,5] The risk of sudden death is 20 times higher in patients with epilepsy compared to the general population and can be stratified according to clinical and genetic factors.[6]

  • We first confirmed that loxTB Htr2c mutant mice did not express 5-HT2C receptors in the brain

  • We found that 16.47% (14/85; Fig. 1C, blue line) of female Htr2cÀ/À mice died prematurely compared with only 4.92% (6/122; Fig. 1, magenta line) of Htr2cÀ/þ and 1.72% (1/58; Fig. 1C, grey line) of female wildtype mice

Read more

Summary

Introduction

Sudden Unexpected Death in Epilepsy (SUDEP) is a leading cause of mortality in individuals with epilepsy, accounting for nearly 3000 deaths per year in the U.S.1–3 In patients with chronic refractory epilepsy, SUDEP is diagnosed as the cause of death in up to 50% of cases.[4,5] The risk of sudden death is 20 times higher in patients with epilepsy compared to the general population and can be stratified according to clinical and genetic factors.[6]. In patients with chronic refractory epilepsy, SUDEP is diagnosed as the cause of death in up to 50% of cases.[4,5] The risk of sudden death is 20 times higher in patients with epilepsy compared to the general population and can be stratified according to clinical and genetic factors.[6] Monogenic epilepsies, such as Dravet Syndrome (SCN1A), provide additional insight into the heterogeneity of SUDEP mechanisms in paediatric epilepsy populations, as well as an opportunity to more precisely identify and treat individuals at increased risk.[7,8,9] Mouse models of these and related genes have been identified that significantly raise early SUDEP risk by impairing cardiorespiratory function following a tonic seizure,[10,11,12,13,14,15,16] while few genes for adult-onset risk have been reported. In heterozygous Scn1a mutants, selective activation of inhibitory neurons by CRISPR-Cas[9] engineering[17] or a specific venom peptide toxin[18] pinpoint the impairment of interneuron firing as a critical mechanism underlying seizures and SUDEP

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call